Laura A. Vallow

ResearcherPublications, citations & collaboration network

Laura A. Vallow is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 161 works, 2,540 citations, an h-index of 23 and an i10-index of 42.

161

Works

2,540

Citations

h-index

i10-index

IDs:OpenAlex

How has Laura A. Vallow's publication output changed over time?

ScholarIQpublication output · 2003–2022

Output grew0% over the shown period — from 1 works in 2003 to 1 in 2022.

2003200820122015201820192022

What are the most-cited papers on Laura A. Vallow?

ScholarIQmost cited works

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

Frank A. Vicini, Reena S. Cecchini, Julia White, Douglas W. Arthur, Thomas B. Julian, Rachel Rabinovitch, Robert R. Kuske, Patricia A. Ganz, David S. Parda, Michael F. Scheier, Kathryn Winter, Soonmyung Paik, Henry M. Kuerer, Laura A. Vallow, Lori J. Pierce, Eleftherios P. Mamounas, Beryl McCormick, Joseph P. Costantino, Harry D. Bear, Isabelle Germain, G.S. Gustafson, Linda Grossheim, Ivy A. Petersen, Richard Hudes, Walter J. Curran, John Bryant, Norman Wolmark

The Lancet. 2019484 CitationsOPEN ACCESS

RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

Beryl McCormick, Kathryn Winter, Clifford A. Hudis, Henry M. Kuerer, Eileen Rakovitch, Barbara L. Smith, Nour Sneige, Jennifer Moughan, Amit Kumar Shah, Isabelle Germain, Alan C. Hartford, Afshin Rashtian, Eleanor Walker, Albert Yuen, Eric A. Strom, Jeannette L. Wilcox, Laura A. Vallow, William Small, Anthony T. Pu, K. Kerlin, Julia White

Journal of Clinical Oncology. 2015397 CitationsOPEN ACCESS

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Richard G. Margolese, Reena S. Cecchini, Thomas B. Julian, Patricia A. Ganz, Joseph P. Costantino, Laura A. Vallow, Kathy S. Albain, Patrick Whitworth, Mary Cianfrocca, Adam Brufsky, Howard M. Gross, Gamini S. Soori, Judith O. Hopkins, Louis Fehrenbacher, Keren Sturtz, Timothy F. Wozniak, Thomas E. Seay, Eleftherios P. Mamounas, Norman Wolmark

The Lancet. 2015198 Citations

Prognostic factors in Merkel cell carcinoma: Analysis of 240 cases

Tina I. Tarantola, Laura A. Vallow, Michele Y. Halyard, Roger H. Weenig, Karen E. Warschaw, Travis E. Grotz, James W. Jakub, Randall K. Roenigk, Jerry D. Brewer, Amy L. Weaver, Clark C. Otley

S58727509. 2012176 Citations

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Patricia A. Ganz, Reena S. Cecchini, Thomas B. Julian, Richard G. Margolese, Joseph P. Costantino, Laura A. Vallow, Kathy S. Albain, Patrick Whitworth, Mary Cianfrocca, Adam Brufsky, Howard M. Gross, Gamini S. Soori, Judith O. Hopkins, Louis Fehrenbacher, Keren Sturtz, Timothy F. Wozniak, Thomas E. Seay, Eleftherios P. Mamounas, Norman Wolmark

The Lancet. 201579 Citations

Related on ScholarIQ

Jacksonville College

Institution

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

Paper

RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

Paper

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Paper

Prognostic factors in Merkel cell carcinoma: Analysis of 240 cases

Paper